{
    "symbol": "TLIS",
    "quarter": 2,
    "year": 2022,
    "date": "2022-08-05 15:48:04",
    "content": " Today, we have an innovative high-performing platform with Talis One evidence that we can manufacture cartridges and instruments at scale and approximately $165 million in cash to execute on our mission to improve health equity and outcomes with highly accurate infectious disease testing in the moment of need. Importantly, this decision allows us to focus our resources on large and long-term market opportunities in women's and sexual health markets where we believe we can deliver the greatest competitive advantages, revenue growth and profit margins."
}